Stryker Corp.

SYK-N

NYSE:SYK

183.94
0.10 (0.05%)
Stryker Corporation is a Fortune 500 medical technologies firm based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and ...
More at Wikipedia

Analysis and Opinions about SYK-N

Signal
Opinion
Expert
TOP PICK
TOP PICK
June 26, 2020
A medical device company. Elective surgeries have been slowed during the pandemic, but will still need to done. Demographics mean this will continue to grow. There is brand loyalty in the space as parts are not easily exchangeable. About 25% of cash flow goes to dividends and the rest towards acquisitions and paying down debt. Yield 1.31% (Analysts’ price target is $205.63)
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
June 26, 2020
A medical device company. Elective surgeries have been slowed during the pandemic, but will still need to done. Demographics mean this will continue to grow. There is brand loyalty in the space as parts are not easily exchangeable. About 25% of cash flow goes to dividends and the rest towards acquisitions and paying down debt. Yield 1.31% (Analysts’ price target is $205.63)
PAST TOP PICK
PAST TOP PICK
May 11, 2020
(A Top Pick May 21/19, Up 4%) It is a good opportunity to buy the stock right here. Elective surgeries are shut down and have to come back. You may have tougher quarters over the next little while.
Show full opinionHide full opinion
(A Top Pick May 21/19, Up 4%) It is a good opportunity to buy the stock right here. Elective surgeries are shut down and have to come back. You may have tougher quarters over the next little while.
DON'T BUY
DON'T BUY
April 23, 2020
The analysts are calling for about $8 a share which gives a PE of 20 at current prices. The fair market value is a little below the current stock price. His target is about $210 and is an upper boundary. The bottom would be $132. (Analysts’ price target is $8.00)
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
April 23, 2020
The analysts are calling for about $8 a share which gives a PE of 20 at current prices. The fair market value is a little below the current stock price. His target is about $210 and is an upper boundary. The bottom would be $132. (Analysts’ price target is $8.00)
PAST TOP PICK
PAST TOP PICK
April 16, 2020
(A Top Pick Jun 04/19, Down 7%) He really likes the equipment side of the healthcare industry. There is a bit of a lag for the kind of procedures they are doing. The demographic is really good and people will continue to need knees and hips and so on. He is looking to add more to this industry. He continues to hold it.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
April 16, 2020
(A Top Pick Jun 04/19, Down 7%) He really likes the equipment side of the healthcare industry. There is a bit of a lag for the kind of procedures they are doing. The demographic is really good and people will continue to need knees and hips and so on. He is looking to add more to this industry. He continues to hold it.
DON'T BUY
DON'T BUY
April 7, 2020

Likes it. He hasn't bought it, because he isn't sure which stock to own in this sector. Abbott and Boston Scientific are better choices, he thinks, with more upside potential given product innovation.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
April 7, 2020

Likes it. He hasn't bought it, because he isn't sure which stock to own in this sector. Abbott and Boston Scientific are better choices, he thinks, with more upside potential given product innovation.

PAST TOP PICK
PAST TOP PICK
March 12, 2020
(A Top Pick May 21/19, Down 16%) Medical devices, which is very strong. It's a practical way to keep people out of hospitals. Great story about demographics.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
March 12, 2020
(A Top Pick May 21/19, Down 16%) Medical devices, which is very strong. It's a practical way to keep people out of hospitals. Great story about demographics.
BUY WEAKNESS
BUY WEAKNESS
February 26, 2020

A great medical equipment company. Over time, they've consolidated and grown. Demographic trends are on his side. But he owns Abbott instead; you can't own everything. Wait for more of a pullback to buy. If the PE falls to the low-$20s, step in.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 26, 2020

A great medical equipment company. Over time, they've consolidated and grown. Demographic trends are on his side. But he owns Abbott instead; you can't own everything. Wait for more of a pullback to buy. If the PE falls to the low-$20s, step in.

TOP PICK
TOP PICK
February 21, 2020

A manufacturer of medical and surgical devices. The company has had positive sales growth for over 40 years. They do a great job at identifying areas where they are weak, finding a way to fill that gap and executing the strategy quickly. There is not much exposure they hold in China -- fortuitous right now. Yield 1.03% (Analysts’ price target is $232.92)

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 21, 2020

A manufacturer of medical and surgical devices. The company has had positive sales growth for over 40 years. They do a great job at identifying areas where they are weak, finding a way to fill that gap and executing the strategy quickly. There is not much exposure they hold in China -- fortuitous right now. Yield 1.03% (Analysts’ price target is $232.92)

TOP PICK
TOP PICK
February 18, 2020
A good acquirer and integrator and have a good position in hip and knee replacement. They're aiming for 1,000 robotic installations worldwide, now at 850. They took a drop in their last purchase but they've bounced back. (Analysts’ price target is $232.92)
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 18, 2020
A good acquirer and integrator and have a good position in hip and knee replacement. They're aiming for 1,000 robotic installations worldwide, now at 850. They took a drop in their last purchase but they've bounced back. (Analysts’ price target is $232.92)
COMMENT
COMMENT
February 14, 2020

Investing in healthcare is hard. He holds BDX which he sees it as the shopping mall of healthcare products. He used to own ZBH but they suffered from recalls. He would probably stick to one of the three since he believes they are the best run companies in healthcare.

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 14, 2020

Investing in healthcare is hard. He holds BDX which he sees it as the shopping mall of healthcare products. He used to own ZBH but they suffered from recalls. He would probably stick to one of the three since he believes they are the best run companies in healthcare.

BUY
BUY
February 11, 2020
Medical devices are a good play on aging US demographics. SYK recently merged with a smaller company to consolidate their hips and knees products. He owns its peers including Boston Scientific, but the whole space is enjoying a nice upside. You can buy SYK.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 11, 2020
Medical devices are a good play on aging US demographics. SYK recently merged with a smaller company to consolidate their hips and knees products. He owns its peers including Boston Scientific, but the whole space is enjoying a nice upside. You can buy SYK.
BUY
BUY
February 6, 2020
Joint replacements. Medical instruments. Great company. Issues with latest acquisition, so stock fell below its high.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
February 6, 2020
Joint replacements. Medical instruments. Great company. Issues with latest acquisition, so stock fell below its high.
COMMENT
COMMENT
January 29, 2020

SYK vs. Anthem He likes both. Stryker trades at 23x PE. He owns Anthem, which hit on earnings, but the market was skittish on their expense line. It's a great healthcare company

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 29, 2020

SYK vs. Anthem He likes both. Stryker trades at 23x PE. He owns Anthem, which hit on earnings, but the market was skittish on their expense line. It's a great healthcare company

PAST TOP PICK
PAST TOP PICK
January 20, 2020
(A Top Pick Jan 04/19, Up 21%) The best, most innovative medical device company around. It's come off its highs recently as it acquired a spinal business, but it has room to run. It's long grown its earnings for many years. They excel at buying small companies specializing in hips, knees and spines.
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 20, 2020
(A Top Pick Jan 04/19, Up 21%) The best, most innovative medical device company around. It's come off its highs recently as it acquired a spinal business, but it has room to run. It's long grown its earnings for many years. They excel at buying small companies specializing in hips, knees and spines.
TOP PICK
TOP PICK
January 17, 2020
A diversified medical devices company. They create a variety of equipment, including orthopaedics and robotic surgery. The company has executed very well. They recently made an acquisition that helps them move into hips, knees and ankles. There is volatility. He would enter around $205-210. (Analysts’ price target is $230.25)
Show full opinionHide full opinion
Stryker Corp. (SYK-N)
January 17, 2020
A diversified medical devices company. They create a variety of equipment, including orthopaedics and robotic surgery. The company has executed very well. They recently made an acquisition that helps them move into hips, knees and ankles. There is volatility. He would enter around $205-210. (Analysts’ price target is $230.25)
Showing 1 to 15 of 90 entries

Stryker Corp.(SYK-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 11

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 3

Total Signals / Votes : 14

Stockchase rating for Stryker Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Stryker Corp.(SYK-N) Frequently Asked Questions

What is Stryker Corp. stock symbol?

Stryker Corp. is a American stock, trading under the symbol SYK-N on the New York Stock Exchange (SYK). It is usually referred to as NYSE:SYK or SYK-N

Is Stryker Corp. a buy or a sell?

In the last year, 14 stock analysts published opinions about SYK-N. 11 analysts recommended to BUY the stock. 3 analysts recommended to SELL the stock. The latest stock analyst recommendation is TOP PICK. Read the latest stock experts' ratings for Stryker Corp..

Is Stryker Corp. a good investment or a top pick?

Stryker Corp. was recommended as a Top Pick by Paul Harris, CFA on 2020-06-26. Read the latest stock experts ratings for Stryker Corp..

Why is Stryker Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Stryker Corp. worth watching?

14 stock analysts on Stockchase covered Stryker Corp. In the last year. It is a trending stock that is worth watching.

What is Stryker Corp. stock price?

On 2020-07-02, Stryker Corp. (SYK-N) stock closed at a price of $183.94.